Revvity, Inc. (RVTY)
131.00
+4.41
(+3.48%)
USD |
NYSE |
Sep 02, 14:16
Revvity Research and Development Expense (TTM) : 215.83M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 215.83M |
| March 31, 2026 | 220.13M |
| December 31, 2025 | 215.84M |
| September 30, 2025 | 206.87M |
| June 30, 2025 | 205.22M |
| March 31, 2025 | 200.08M |
| December 31, 2024 | 196.84M |
| September 30, 2024 | 197.23M |
| June 30, 2024 | 201.13M |
| March 31, 2024 | 210.25M |
| December 31, 2023 | 216.58M |
| September 30, 2023 | 221.52M |
| June 30, 2023 | 222.00M |
| March 31, 2023 | 220.78M |
| December 31, 2022 | 240.70M |
| September 30, 2022 | 246.75M |
| June 30, 2022 | 242.65M |
| March 31, 2022 | 252.44M |
| December 31, 2021 | 236.04M |
| September 30, 2021 | 232.28M |
| June 30, 2021 | 232.99M |
| March 31, 2021 | 216.69M |
| December 31, 2020 | 205.39M |
| September 30, 2020 | 196.20M |
| June 30, 2020 | 191.45M |
| Date | Value |
|---|---|
| March 31, 2020 | 190.27M |
| December 31, 2019 | 189.34M |
| September 30, 2019 | 189.57M |
| June 30, 2019 | 189.34M |
| March 31, 2019 | 188.19M |
| December 31, 2018 | 186.20M |
| September 30, 2018 | 175.96M |
| June 30, 2018 | 165.60M |
| March 31, 2018 | 151.96M |
| December 31, 2017 | 139.27M |
| September 30, 2017 | 134.56M |
| June 30, 2017 | 129.18M |
| March 31, 2017 | 127.29M |
| December 31, 2016 | 123.78M |
| September 30, 2016 | 120.78M |
| June 30, 2016 | 122.36M |
| March 31, 2016 | 123.28M |
| December 31, 2015 | 125.53M |
| September 30, 2015 | 126.36M |
| June 30, 2015 | 125.61M |
| March 31, 2015 | 123.28M |
| December 31, 2014 | 120.51M |
| September 30, 2014 | 122.35M |
| June 30, 2014 | 123.34M |
| March 31, 2014 | 127.60M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Agilent Technologies, Inc. | 480.00M |
| Thermo Fisher Scientific, Inc. | 1.403B |
| Danaher Corp. | 1.615B |
| Waters Corp. | 319.74M |
| Bio-Rad Laboratories, Inc. | 260.70M |